A vast number of studies has provided evidence indicating that activation of peripheral CB1R located in insulin-dependent tissues, i.e., liver, adipose tissue, or skeletal muscles, is widely associated with the development of dyslipidemia, insulin resistance, and type 2 diabetes [66]. This evidence concerns the gene CNR1 and type 2 diabetes mellitus.